2026. Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland. Swiss Medical Weekly. 156, 6 (Jun. 2026), 5062. DOI:https://doi.org/10.57187/5062.